StockNews.AISignal intelligence
Aehr Test Systems · NASDAQ · Technology
Browse public AEHR signals with their source context and measured market impact. Open any signal for its permanent analysis page.
Aehr announced a production-order expansion for its FOX-XP burn-in system to scale silicon photonics IC production, signaling manufacturing-scale adoption. The nine WaferPak blades support up to 3,500 watts, with shipments expected in H1 2027. AI infrastructure demand is cited as accelerating silicon photonics use, potentially driving AEHR's long-term growth.
View signal analysisAehr reported a strong Q4 with $18.8M revenue, record $60.7M bookings, and $80.6M backlog. For FY2026, revenue was $50.0M and non-GAAP profit turned positive, while GAAP loss narrowed. The company guides FY2027 revenue of $130–$150M (up roughly 160–200% YoY) supported by an ~$100M backlog, broad AI, silicon photonics, and SiC/GaN opportunities.
View signal analysisAehr posted a strong Q4 2026 with record bookings of $60.7M and a backlog of $80.6M (effective $100.6M). The company guides fiscal 2027 revenue of $130-150M, implying 160-200% YoY growth, underpinned by AI WLBI, silicon photonics, and SiC/GaN demand. Management emphasized multiple high-potential AI and data-center opportunities ahead.
View signal analysisAehr Test Systems announced Q3 results with $37.2 million in bookings, highlighting strong demand for its burn-in solutions in AI applications. The company is positioned for a significant order ramp-up, potentially stabilizing revenue despite a year-on-year decline in revenue. Increased cash reserves enable better support for operational growth and scalability.
View signal analysisAehr’s Q2 FY2026 revenue dropped 27% year-over-year. The company missed revenue estimates and faced operational challenges. Aehr aims to capture growth in the AI market in H2. Future success depends on uncertain AI demand and significant bookings potential. The company is currently experiencing cash burn related to these challenges.
View signal analysisAEHR missed Q2 revenue estimates by 14.72%. Quarterly revenue dropped to $9.88 million from $13.45 million last year. CEO expresses optimism about future prospects despite revenue dip. Bookings for Q2 were $6.2 million, with a backlog of $11.8 million. Stock price fell 7.75% to $20.94 after earnings report.
View signal analysis